Collagen Assembly in Tissue-Engineered Cartilage
组织工程软骨中的胶原蛋白组装
基本信息
- 批准号:8053852
- 负责人:
- 金额:$ 30.33万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-01 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:Absorbable ImplantsAddressAdultAntibodiesAppearanceArchitectureAwardBenchmarkingBio-BaseBiological MarkersBiomechanicsBiomedical EngineeringCaliberCartilageCartilage MatrixChondrocytesChondrogenesisCollagenCollagen ArthritisCollagen FibrilCollagen Type IICollagen Type IXCollagen Type XIComplexDefectDorsalElectron MicroscopyEngineeringEnzyme-Linked Immunosorbent AssayEventExtracellular MatrixFibrillar CollagenFingerprintFoundationsFutureGoalsGrowthHealedHumanHyaline CartilageKnowledgeMass Spectrum AnalysisMeasuresMesenchymal Stem CellsMethodologyMethodsMinorMolecularMolecular ProfilingMonitorNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNude MiceOutcome MeasurePainPathway interactionsPatternPeptidesPhenotypePolymersPropertyProtein ChemistryProteomicsShockStem cellsStructureTechniquesTimeTissue EngineeringTissuesTransplantationWestern Blottingarticular cartilagebasebiodegradable polymercrosslinkdensityfibrillogenesishealingin vivoindexingjoint functionmolecular assembly/self assemblypublic health relevanceresponsesoundsubcutaneoustool
项目摘要
DESCRIPTION (provided by applicant): The ability of cartilage to act as a shock absorber depends on the quality of the collagen fibrillar network that frames cartilage. This network is made up of three different types of collagen (types II, IX and XI) assembled and precisely cross-linked together into heteropolymers. Despite many advances in the field of cartilage tissue engineering, a continuous challenge has been to increase the collagen content of bioengineered cartilage to levels observed in native articular cartilage. Since the collagen heteropolymer is a crucial template of the mature fibrillar architecture and for the ongoing stability of the mature tissue, we hypothesize that a cross-linked template of type II/IX/XI collagen heterofibrils must sequentially assemble in the matrix of newly forming cartilage to allow type II collagen fibril growth, an increased collagen content and so achieve the biomechanical properties of functional articular cartilage. Whether correct cross-linked assemblies of the minor collagen template (types IX and XI) with type II collagen form in neo-cartilage, is not well characterized. Our goal is to determine if a collagen network typical of hyaline cartilage is assembled in chondrocyte based and mesenchymal stem cell based bio-engineered tissues. Since the minor collagens regulate the organization of the network, (e.g., collagen fibril diameter modulated by type XI/V collagen), fingerprinting the pattern of collagen inter-type cross-linking can provide a screen for normal matrix assembly and a valuable tool in understanding the sequence of events in the fibrillogenesis of the type II/IX/XI collagen fibril in adult mesenchymal stem cells undergoing chondrogenesis. The aim is to use Western blot, ELISA, LC-mass spectrometry, and other advanced methods in protein chemistry to establish a molecular fingerprint of the collagen fibril assembly and a set of parameters to use as a biomarker to better evaluate the cross-linked collagen network in normal and engineered cartilage. The ultimate goal is to validate proteomic methods to use as an outcome measure of tissue engineered cartilage that has the collagen content, quality and structural properties of articular cartilage needed to transplant into cartilage defects. The goals also include laying the foundation for evaluating the changing quality of cartilage produced as a healing response.
PUBLIC HEALTH RELEVANCE: The ability of cartilage to act as a shock absorber depends on the quality of the collagen heterofibrillar network that frames cartilage. In arthritis, this collagen network is broken down leading to a loss of normal joint function and severe pain. The goal of this study is to develop and authenticate a biomarker to monitor if this collagen heterofibrillar network assembled in bioengineered cartilage is typical of normal cartilage.
描述(由申请人提供):软骨作为减震器的能力取决于构成软骨的胶原纤维网络的质量。该网络由三种不同类型的胶原蛋白(II 型、IX 型和 XI 型)组成,它们组装并精确交联在一起形成杂聚物。 尽管软骨组织工程领域取得了许多进展,但将生物工程软骨的胶原蛋白含量增加到天然关节软骨中观察到的水平一直是一个持续的挑战。由于胶原异聚物是成熟原纤维结构的重要模板,对于成熟组织的持续稳定性来说,我们假设 II/IX/XI 型胶原异原纤维的交联模板必须顺序组装在新形成的软骨基质中使 II 型胶原原纤维生长,增加胶原蛋白含量,从而实现功能性关节软骨的生物力学特性。新软骨中次要胶原蛋白模板(IX 型和 XI 型)与 II 型胶原蛋白形式的正确交联组装是否正确尚不清楚。 我们的目标是确定透明软骨典型的胶原蛋白网络是否组装在基于软骨细胞和基于间充质干细胞的生物工程组织中。由于次要胶原蛋白调节网络的组织(例如,由 XI/V 型胶原蛋白调节的胶原原纤维直径),因此对胶原蛋白类型间交联模式进行指纹识别可以为正常基质组装提供筛选,并为研究提供有价值的工具。了解正在经历软骨形成的成体间充质干细胞中 II/IX/XI 型胶原原纤维的原纤维形成的事件顺序。目的是利用蛋白质印迹、ELISA、LC-质谱和蛋白质化学中的其他先进方法来建立胶原原纤维组装的分子指纹和一组参数,以用作生物标志物,以更好地评估交联胶原蛋白正常和工程软骨中的网络。 最终目标是验证蛋白质组学方法,以用作组织工程软骨的结果测量,该软骨具有移植软骨缺损所需的关节软骨的胶原蛋白含量、质量和结构特性。这些目标还包括为评估作为愈合反应而产生的软骨质量变化奠定基础。
公众健康相关性:软骨作为减震器的能力取决于构成软骨的胶原异原纤维网络的质量。在关节炎中,这种胶原蛋白网络被破坏,导致正常关节功能丧失和剧烈疼痛。本研究的目的是开发和验证一种生物标记物,以监测生物工程软骨中组装的胶原异原纤维网络是否是正常软骨的典型特征。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RUSSELL J FERNANDES其他文献
RUSSELL J FERNANDES的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RUSSELL J FERNANDES', 18)}}的其他基金
Collagen Assembly in Tissue-Engineered Cartilage
组织工程软骨中的胶原蛋白组装
- 批准号:
8450133 - 财政年份:2010
- 资助金额:
$ 30.33万 - 项目类别:
Collagen Assembly in Tissue-Engineered Cartilage
组织工程软骨中的胶原蛋白组装
- 批准号:
8234165 - 财政年份:2010
- 资助金额:
$ 30.33万 - 项目类别:
Collagen Assembly in Tissue-Engineered Cartilage
组织工程软骨中的胶原蛋白组装
- 批准号:
7897563 - 财政年份:2010
- 资助金额:
$ 30.33万 - 项目类别:
Collagen type II/IX/XI heteropolymer assembly
II/IX/XI 型胶原蛋白杂聚物组装体
- 批准号:
6965219 - 财政年份:2005
- 资助金额:
$ 30.33万 - 项目类别:
Collagen type II/IX/XI heteropolymer assembly
II/IX/XI 型胶原蛋白杂聚物组装体
- 批准号:
7242645 - 财政年份:2005
- 资助金额:
$ 30.33万 - 项目类别:
Collagen type II/IX/XI heteropolymer assembly
II/IX/XI 型胶原蛋白杂聚物组装体
- 批准号:
7087978 - 财政年份:2005
- 资助金额:
$ 30.33万 - 项目类别:
相似国自然基金
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Longitudinal Modeling of Pro-Inflammatory Cytokines, Hazardous Alcohol Use, and Cerebral Metabolites as Predictors of Neurocognitive Change in People with HIV
促炎细胞因子、有害酒精使用和脑代谢物的纵向建模作为 HIV 感染者神经认知变化的预测因子
- 批准号:
10838849 - 财政年份:2024
- 资助金额:
$ 30.33万 - 项目类别:
Uncovering Mechanisms of Racial Inequalities in ADRD: Psychosocial Risk and Resilience Factors for White Matter Integrity
揭示 ADRD 中种族不平等的机制:心理社会风险和白质完整性的弹性因素
- 批准号:
10676358 - 财政年份:2024
- 资助金额:
$ 30.33万 - 项目类别:
Developing Real-world Understanding of Medical Music therapy using the Electronic Health Record (DRUMMER)
使用电子健康记录 (DRUMMER) 培养对医学音乐治疗的真实理解
- 批准号:
10748859 - 财政年份:2024
- 资助金额:
$ 30.33万 - 项目类别:
A HUMAN IPSC-BASED ORGANOID PLATFORM FOR STUDYING MATERNAL HYPERGLYCEMIA-INDUCED CONGENITAL HEART DEFECTS
基于人体 IPSC 的类器官平台,用于研究母亲高血糖引起的先天性心脏缺陷
- 批准号:
10752276 - 财政年份:2024
- 资助金额:
$ 30.33万 - 项目类别:
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 30.33万 - 项目类别: